| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.33 | 0.07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |